Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
39.59
+0.65 (1.67%)
Nov 22, 2024, 4:00 PM EST - Market closed

Veracyte Statistics

Total Valuation

Veracyte has a market cap or net worth of $3.07 billion. The enterprise value is $2.81 billion.

Market Cap 3.07B
Enterprise Value 2.81B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date Nov 6, 2024
Ex-Dividend Date n/a

Share Statistics

Veracyte has 77.50 million shares outstanding. The number of shares has increased by 4.20% in one year.

Current Share Class 77.50M
Shares Outstanding 77.50M
Shares Change (YoY) +4.20%
Shares Change (QoQ) +1.69%
Owned by Insiders (%) 0.41%
Owned by Institutions (%) 107.19%
Float 77.18M

Valuation Ratios

PE Ratio n/a
Forward PE 43.52
PS Ratio 7.01
Forward PS 6.77
PB Ratio 2.61
P/TBV Ratio 10.06
P/FCF Ratio 54.32
P/OCF Ratio 46.40
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 63.93, with an EV/FCF ratio of 49.82.

EV / Earnings n/a
EV / Sales 6.62
EV / EBITDA 63.93
EV / EBIT 137.45
EV / FCF 49.82

Financial Position

The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.02.

Current Ratio 5.08
Quick Ratio 4.59
Debt / Equity 0.02
Debt / EBITDA 0.37
Debt / FCF 0.35
Interest Coverage 5,118.00

Financial Efficiency

Return on equity (ROE) is -0.83% and return on invested capital (ROIC) is 1.13%.

Return on Equity (ROE) -0.83%
Return on Assets (ROA) 1.07%
Return on Capital (ROIC) 1.13%
Revenue Per Employee $521,879
Profits Per Employee -$11,372
Employee Count 815
Asset Turnover 0.35
Inventory Turnover 7.08

Taxes

In the past 12 months, Veracyte has paid $1.10 million in taxes.

Income Tax 1.10M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +57.23% in the last 52 weeks. The beta is 1.67, so Veracyte's price volatility has been higher than the market average.

Beta (5Y) 1.67
52-Week Price Change +57.23%
50-Day Moving Average 34.89
200-Day Moving Average 26.39
Relative Strength Index (RSI) 63.29
Average Volume (20 Days) 888,835

Short Selling Information

The latest short interest is 3.10 million, so 4.00% of the outstanding shares have been sold short.

Short Interest 3.10M
Short Previous Month 3.10M
Short % of Shares Out 4.00%
Short % of Float 4.02%
Short Ratio (days to cover) 4.66

Income Statement

In the last 12 months, Veracyte had revenue of $425.33 million and -$9.27 million in losses. Loss per share was -$0.12.

Revenue 425.33M
Gross Profit 296.96M
Operating Income 20.47M
Pretax Income -54.79M
Net Income -9.27M
EBITDA 44.01M
EBIT 20.47M
Loss Per Share -$0.12
Full Income Statement

Balance Sheet

The company has $274.08 million in cash and $19.79 million in debt, giving a net cash position of $254.29 million or $3.28 per share.

Cash & Cash Equivalents 274.08M
Total Debt 19.79M
Net Cash 254.29M
Net Cash Per Share $3.28
Equity (Book Value) 1.18B
Book Value Per Share 15.18
Working Capital 286.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $66.12 million and capital expenditures -$9.64 million, giving a free cash flow of $56.48 million.

Operating Cash Flow 66.12M
Capital Expenditures -9.64M
Free Cash Flow 56.48M
FCF Per Share $0.73
Full Cash Flow Statement

Margins

Gross margin is 69.82%, with operating and profit margins of 4.81% and -2.18%.

Gross Margin 69.82%
Operating Margin 4.81%
Pretax Margin -1.92%
Profit Margin -2.18%
EBITDA Margin 10.35%
EBIT Margin 4.81%
FCF Margin 10.04%

Dividends & Yields

Veracyte does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.20%
Shareholder Yield -4.20%
Earnings Yield -0.30%
FCF Yield 1.84%
Dividend Details

Analyst Forecast

The average price target for Veracyte is $40.00, which is 1.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target $40.00
Price Target Difference 1.04%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Veracyte has an Altman Z-Score of 11.26 and a Piotroski F-Score of 6.

Altman Z-Score 11.26
Piotroski F-Score 6